44 related articles for article (PubMed ID: 4096878)
1. Trabecular bone remodeling and bone balance in hyperthyroidism.
Eriksen EF; Mosekilde L; Melsen F
Bone; 1985; 6(6):421-8. PubMed ID: 4096878
[TBL] [Abstract][Full Text] [Related]
2. Causal relationship between thyroid dysfunction and hallux valgus: A two-sample Mendelian randomization study.
Xiong B; Bai Z; Cao X; Nie D; Zhang C; Sun X; Guo Z; Wen J; Sun W
Front Endocrinol (Lausanne); 2023; 14():1115834. PubMed ID: 36967762
[TBL] [Abstract][Full Text] [Related]
3. Bone Turnover in Relation to Thyroid-Stimulating Hormone in Hypothyroid Patients on Thyroid Hormone Substitution Therapy.
Bjerkreim BA; Hammerstad SS; Eriksen EF
J Thyroid Res; 2022; 2022():8950546. PubMed ID: 36248357
[TBL] [Abstract][Full Text] [Related]
4. IL-15 deficiency alleviates steroid-induced osteonecrosis of the femoral head by impact osteoclasts via RANKL-RANK-OPG system.
Zhou Z; Lin Y; Pan C; Wang N; Zhou L; Shan H; Gao Y; Yu X
Immun Ageing; 2020; 17():19. PubMed ID: 32536957
[TBL] [Abstract][Full Text] [Related]
5. Influence of Thyroid-stimulating Hormone Suppression Therapy on Bone Mineral Density in Patients with Differentiated Thyroid Cancer: A Meta-analysis.
Yoon BH; Lee Y; Oh HJ; Kim SH; Lee YK
J Bone Metab; 2019 Feb; 26(1):51-60. PubMed ID: 30899725
[TBL] [Abstract][Full Text] [Related]
6. Effects of Thyrotropin Suppression on Bone Health in Menopausal Women with Total Thyroidectomy.
Kim EH; Jeon YK; Pak K; Kim IJ; Kim SJ; Shin S; Kim BH; Kim SS; Lee BJ; Lee JG; Goh TS; Kim K
J Bone Metab; 2019 Feb; 26(1):31-38. PubMed ID: 30899722
[TBL] [Abstract][Full Text] [Related]
7. Changes in bone mineral density and trabecular bone score in Graves' disease patients after anti-thyroid therapy.
Ock SY; Chung YS; Choi YJ
Osteoporos Sarcopenia; 2016 Sep; 2(3):175-179. PubMed ID: 30775484
[TBL] [Abstract][Full Text] [Related]
8. TSH-receptor antibodies may prevent bone loss in pre- and postmenopausal women with Graves' disease and Graves' orbitopathy.
Siderova M; Hristozov K; Tsukeva A
Arch Endocrinol Metab; 2018; 62(2):221-226. PubMed ID: 29768627
[TBL] [Abstract][Full Text] [Related]
9. Thyroid Hormone Signaling in the Development of the Endochondral Skeleton.
Lindsey RC; Aghajanian P; Mohan S
Vitam Horm; 2018; 106():351-381. PubMed ID: 29407442
[TBL] [Abstract][Full Text] [Related]
10. Hypercalcemic Disorders in Children.
Stokes VJ; Nielsen MF; Hannan FM; Thakker RV
J Bone Miner Res; 2017 Nov; 32(11):2157-2170. PubMed ID: 28914984
[TBL] [Abstract][Full Text] [Related]
11. Effects of Bone Marrow Mesenchymal Stem Cells-Conditioned Medium on Tibial Partial Osteotomy Model of Fracture Healing in Hypothyroidism Rats.
Sefati N; Norouzian M; Abbaszadeh HA; Abdollahifar MA; Amini A; Bagheri M; Aryan A; Fadaei Fathabady F
Iran Biomed J; 2018 Mar; 22(2):90-8. PubMed ID: 28755654
[TBL] [Abstract][Full Text] [Related]
12. Role of Thyroid Hormones in Skeletal Development and Bone Maintenance.
Bassett JH; Williams GR
Endocr Rev; 2016 Apr; 37(2):135-87. PubMed ID: 26862888
[TBL] [Abstract][Full Text] [Related]
13. Lack of α2C-Adrenoceptor Results in Contrasting Phenotypes of Long Bones and Vertebra and Prevents the Thyrotoxicosis-Induced Osteopenia.
Cruz Grecco Teixeira MB; Martins GM; Miranda-Rodrigues M; De Araújo IF; Oliveira R; Brum PC; Azevedo Gouveia CH
PLoS One; 2016; 11(1):e0146795. PubMed ID: 26815679
[TBL] [Abstract][Full Text] [Related]
14. High-normal free thyroxine levels are associated with low trabecular bone scores in euthyroid postmenopausal women.
Hwangbo Y; Kim JH; Kim SW; Park YJ; Park DJ; Kim SY; Shin CS; Cho NH
Osteoporos Int; 2016 Feb; 27(2):457-62. PubMed ID: 26252978
[TBL] [Abstract][Full Text] [Related]
15. Achyranthes bidentata extract exerts osteoprotective effects on steroid-induced osteonecrosis of the femoral head in rats by regulating RANKL/RANK/OPG signaling.
Jiang Y; Zhang Y; Chen W; Liu C; Li X; Sun D; Liu Z; Xu Y; Mao X; Guo Q; Lin N
J Transl Med; 2014 Nov; 12():334. PubMed ID: 25471933
[TBL] [Abstract][Full Text] [Related]
16. Effects of Levothyroxine and thyroid stimulating hormone on bone loss in patients with primary hypothyroidism.
Karimifar M; Esmaili F; Salari A; Kachuei A; Faragzadegan Z; Karimifar M
J Res Pharm Pract; 2014 Jul; 3(3):83-7. PubMed ID: 25328897
[TBL] [Abstract][Full Text] [Related]
17. Utility of C-terminal Telopeptide in Evaluating Levothyroxine Replacement Therapy-Induced Bone Loss.
Christy AL; D'Souza V; Babu RP; Takodara S; Manjrekar P; Hegde A; Rukmini MS
Biomark Insights; 2014; 9():1-6. PubMed ID: 24634578
[TBL] [Abstract][Full Text] [Related]
18. Metabolic and clinical consequences of hyperthyroidism on bone density.
Gorka J; Taylor-Gjevre RM; Arnason T
Int J Endocrinol; 2013; 2013():638727. PubMed ID: 23970897
[TBL] [Abstract][Full Text] [Related]
19. Vitamin E management of oxidative damage-linked dysfunctions of hyperthyroid tissues.
Venditti P; Di Stefano L; Di Meo S
Cell Mol Life Sci; 2013 Sep; 70(17):3125-44. PubMed ID: 23255045
[TBL] [Abstract][Full Text] [Related]
20. Levothyroxine dose and risk of fractures in older adults: nested case-control study.
Turner MR; Camacho X; Fischer HD; Austin PC; Anderson GM; Rochon PA; Lipscombe LL
BMJ; 2011 Apr; 342():d2238. PubMed ID: 21527461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
